Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot clinical trial with Mircera in dialysis patients at A.O. San Giovanni Battista di Torino
2009-011497-15Phase 4Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Apr 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of Epoetin alfa RB in end-stage kidney disease (ESKD) and anaemia (2 arms), sponsored by AOU Città della Salute e della Scienza di Torino. Primary endpoints: Noninferiority and safety of Mircera vs conventional epoetin therapy, Stability of hemoglobin values and 4 more. Started Apr 2009; status: active.
02
Drugs
Epoetin alfa RB
03
Conditions
end-stage kidney disease (ESKD)anaemia
Beyond the preview
Go deeper on 2009-011497-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011497-15.